A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

CERO), a micro-cap immunotherapy company with a market value of $2.61 million, announced preclinical findings of its lead compound CER-1236 for ovarian cancer at the 2025 SITC Spring Scientific ...

Phase 3 Ovarian Cancer Trial to Initiate in March 2025 ... SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website ...

Initial results for the Phase 2 OVATION-2 Trial were released in July 2024 and for a full analysis of the results please see our previous report here. Briefly, the results showed that in the ...

Kiwi deputy principal Nick Edwards was moved to fundraise for Ovarian Cancer New Zealand after ... goggles and a swim cap, to fulfil marathon swimming rules. This also means he cannot have ...

Amidst global market turbulence, Asian markets have shown resilience, with Japan's stock indices experiencing modest gains and China's markets buoyed by stimulus hopes. In such an environment, ...

There were only four harness races on the dual code card at Wingatui today and female drivers wearing Team Teal ...

Verastem's assets, Avutometinib and Defactinib, show promising results in treating KRAS-mutated LGSOC. Read why VSTM stock is a Hold.

Headquartered in Fort Myers, FL, NeoGenomics operates a network of CAP-accredited and CLIA-certified laboratories ... Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been given an average rating of “Hold” by the ...